» Articles » PMID: 12683824

Using Bifunctional Polymers Presenting Vancomycin and Fluorescein Groups to Direct Anti-fluorescein Antibodies to Self-assembled Monolayers Presenting D-alanine-d-alanine Groups

Overview
Journal J Am Chem Soc
Specialty Chemistry
Date 2003 Apr 10
PMID 12683824
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

This paper describes the synthesis of bifunctional polyacrylamides containing pendant vancomycin (Van) and fluorescein groups, and the use of these polymers to direct antibodies against fluorescein to self-assembled monolayers (SAMs) presenting d-alanine-d-alanine (dAdA) groups. These polymers bind biospecifically to these SAMs via interactions between the dAdA and Van groups and serve as a molecular bridge between the anti-fluorescein antibodies and the SAM. The binding events were characterized using surface plasmon resonance spectroscopy and fluorescence microscopy. The paper demonstrates that polyvalent, biospecific, noncovalent interactions between a polymer and a surface can be used to tailor the properties of the surface in molecular recognition. It also represents a first step toward the design of polymers that direct arbitrarily chosen antibodies to the surfaces of cells.

Citing Articles

Biocompatible antibiotic-coupled nickel-titanium nanoparticles as a potential coating material for biomedical devices.

McGlumphy S, Damai A, Salameh L, Corbin G, Wang Q, Markiewicz J Heliyon. 2024; 10(10):e31434.

PMID: 38831845 PMC: 11145499. DOI: 10.1016/j.heliyon.2024.e31434.


Synthesis and Photophysical Properties of Fluorescein Esters as Potential Organic Semiconductor Materials.

Mostafa G, Mahajumi A, Alrabiah H, Kadi A, Lu Y, Rahman A J Fluoresc. 2021; 31(5):1489-1502.

PMID: 34287764 DOI: 10.1007/s10895-021-02789-y.


Multivalent Antibody-Recruiting Macromolecules: Linking Increased Binding Affinity with Enhanced Innate Immune Killing.

Uvyn A, De Geest B Chembiochem. 2020; 21(21):3036-3043.

PMID: 32497371 PMC: 7116353. DOI: 10.1002/cbic.202000261.


Synthetic Immunotherapeutics against Gram-negative Pathogens.

Feigman M, Kim S, Pidgeon S, Yu Y, Ongwae G, Patel D Cell Chem Biol. 2018; 25(10):1185-1194.e5.

PMID: 29983273 PMC: 6195440. DOI: 10.1016/j.chembiol.2018.05.019.


Synthetic Immunobiotics: A Future Success Story in Small Molecule-Based Immunotherapy?.

Feigman M, Pires M ACS Infect Dis. 2018; 4(5):664-672.

PMID: 29431421 PMC: 9274614. DOI: 10.1021/acsinfecdis.7b00261.